Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Role of transforming growth factor β in cancer microenvironment
Authors
Luis de la Cruz-Merino
Fernando Henao-Carrasco
Teresa García-Manrique
Pedro M. Fernández-Salguero
Manuel Codes-Manuel de Villena
Publication date
01-11-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 11/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0433-8

Other articles of this Issue 11/2009

Clinical and Translational Oncology 11/2009 Go to the issue

Educational Series

Telomerase deficiency and cancer susceptibility syndromes

Research Articles

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

Reviews

Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer

Case Reports

Chylothorax due to metastatic prostate carcinoma: an unusual complication

Case Reports

Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

Case Reports

Intra-abdominal desmoplastic small round cell tumour in a 39-year-old man
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits